Global Leading Market Research Publisher QYResearch announces the release of its latest report “Biopharmaceutical Feeding Bags – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Biopharmaceutical Feeding Bags market, including market size, share, demand, industry development status, and forecasts for the next few years.
For biopharmaceutical manufacturers (mAbs, vaccines, cell therapies), fed-batch and continuous bioreactor processes require sterile, controlled addition of concentrated nutrients, inducers, and pH adjusters. Traditional stainless steel feed vessels require cleaning validation and are inflexible for multi-product facilities. The biopharmaceutical feeding bag addresses this through single-use nutrient transfer: flexible, biocompatible bags with sterile ports for aseptic connection to bioreactors, enabling controlled feeding while eliminating cleaning validation and cross-contamination risk. According to QYResearch’s updated model, the global market for Biopharmaceutical Feeding Bags was estimated to be worth US$ 267 million in 2025 and is projected to reach US$ 357 million, growing at a CAGR of 4.3% from 2026 to 2032. In 2024, global Biopharmaceutical Feeding Bags sales reached approximately 7,800,000 units, with an average global market price of around US$ 31 per unit. Biopharmaceutical Feeding Bags are single-use solutions for sterile material transfer to bioreactors or fermentation systems, commonly used in fed-batch or continuous cultures. Made of biocompatible films, they store concentrated nutrients, inducers, or pH adjusters, connecting to reactors via sterile ports for controlled feeding. Key design features include chemical resistance (to acids/bases/solvents), mechanical durability (puncture-proof), and low leachables to ensure safety during storage or transport. Some bags employ oxygen-barrier layers or light-blocking materials to protect photosensitive compounds. In monoclonal antibody or recombinant protein production, their closed operation prevents contamination while streamlining supply chains. Standardized interfaces ensure compatibility with mainstream bioreactors for seamless process integration.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6095888/biopharmaceutical-feeding-bags
1. Technical Architecture: Capacity and Applications
Biopharmaceutical feeding bags are segmented by volume capacity, determining scale of bioprocessing operations:
| Capacity Range | Typical Fill Volume | Applications | Film Type | Price (USD) | Market Share (Units) |
|---|---|---|---|---|---|
| 5L-20L | 3-16L | Lab-scale bioreactors (1-10L), R&D, process development, cell therapy (small batches) | Single-layer or 2-layer (PE) | $15-25 | 50% |
| 20L-50L | 15-40L | Pilot-scale bioreactors (50-200L), clinical trial manufacturing | 3-layer (PE/EVOH/PE) oxygen barrier | $25-40 | 35% |
| Others (50L-200L) | 40-150L | Commercial-scale bioreactors (500-2,000L), mAb manufacturing, vaccine production | 5-layer (oxygen barrier, light-blocking) | $40-80 | 15% |
Key technical challenge – oxygen barrier for sensitive nutrients: Some media components (amino acids, vitamins) are oxygen-sensitive. Over the past six months, several advancements have emerged:
- Duoning Biotech (February 2026) introduced a 5-layer film (PE/EVOH/PE/EVOH/PE) with oxygen transmission rate (OTR) <0.5 cc/m²/day (vs. 5-10 cc/m²/day for standard bags), extending shelf life of oxygen-sensitive feed solutions from 6 to 18 months.
- LePure Biotech (March 2026) commercialized a light-blocking feeding bag (black PE layer) for photosensitive compounds (retinol, riboflavin, certain antibiotics), preventing photodegradation during storage and transport.
- BioLink (January 2026) launched a feeding bag with integrated sterile filter (0.2μm) and tubing set, enabling sterile connection to bioreactor without additional components, reducing contamination risk and assembly time.
Industry insight – unit economics: 7.8 million units in 2024, ASP $31. Cost breakdown: multilayer film (30-40%), ports/fittings (15-20%), tubing (10-15%), sterile packaging (5-10%), gamma irradiation (5-10%), assembly/testing (10-15%). 5L-20L bags lowest ASP ($15-25), 50L-200L highest ($40-80). Bulk discounts for large-volume users (10-20% for 10,000+ units).
2. Market Segmentation: Capacity and Application
The Biopharmaceutical Feeding Bags market is segmented as below:
Key Players: Duoning Biotech (China), BioLink (China), LePure Biotech (China), Tofflon (China), BioCana (Canada), Ezi-Dock Systems (US), Applitech (China), Topgun Biotech (China), CHANSE (China)
Segment by Capacity:
- 5L-20L – Largest segment (50% of 2024 units). R&D, process development, cell therapy.
- 20L-50L – 35% of units. Pilot-scale, clinical trial manufacturing.
- Others (50L-200L) – 15% of units (fastest-growing, 5% CAGR). Commercial-scale mAb, vaccine.
Segment by Application:
- Bioprocessing – Largest segment (70% of revenue). mAb production (CHO cells), recombinant proteins (E. coli, yeast), vaccine production (Vero, MDCK cells).
- Cell Therapy – 15% of revenue (fastest-growing, 7% CAGR). CAR-T, TCR-T, NK cell expansion (feeder bags for nutrient feeding).
- Gene Therapy – 10% of revenue. AAV, lentivirus production (HEK293 cells).
- Others – Perfusion culture, continuous bioprocessing (5% of revenue).
Typical user case – mAb fed-batch production: A 2,000L mAb manufacturing facility uses 20L feeding bags (Duoning, $30 each) for daily nutrient feeding (glucose, glutamine, concentrated feed media). Each bag contains 15L of feed solution. 10 bags per bioreactor per batch (10 days). Annual volume: 100 batches × 10 bioreactors × 10 bags = 10,000 bags. Cost: $300,000 annually. Benefits: eliminates stainless steel feed vessels (no CIP/SIP), reduces contamination risk, and enables flexible feeding schedules. Payback: 6 months.
Exclusive observation – “pre-sterilized, pre-filled” feeding bags: Some suppliers offer pre-sterilized, pre-filled feeding bags (customer provides feed media, supplier fills and gamma irradiates). This eliminates customer filling operations (reducing contamination risk and labor). Pre-filled bags have ASP $50-150 (2-5x empty bags). Growing at 8% CAGR for cell therapy and gene therapy (high-value, low-volume).
3. Regional Dynamics and Biopharma Manufacturing
| Region | Market Share (2024) | Key Drivers |
|---|---|---|
| Asia-Pacific | 50% | Largest biopharma manufacturing (China), domestic bag suppliers (Duoning, BioLink, LePure, Tofflon, Applitech, Topgun, CHANSE), cost leadership |
| North America | 25% | mAb and cell therapy manufacturing (US), high automation adoption |
| Europe | 20% | Vaccine production (EU), mAbs (Switzerland, Germany, UK) |
| RoW | 5% | Emerging biopharma (Brazil, Singapore) |
Exclusive observation – “custom bag” manufacturing: Many feeding bags are custom-designed for specific bioreactor models (Sartorius, Cytiva, Thermo Fisher). Custom bags include specific port configurations (number, size, type) and tubing lengths. Custom bag ASP 20-30% higher than standard. Custom segment growing at 6% CAGR as biopharma companies standardize on specific bioreactor platforms.
4. Competitive Landscape and Outlook
| Tier | Supplier | Key Strengths | Focus |
|---|---|---|---|
| 1 | Global leaders | Cytiva (not listed), Sartorius (not listed) (indirectly via OEM supply) | Full single-use bioprocessing portfolio, global distribution (but limited direct presence in China domestic market) |
| 1 | Chinese domestic leaders | Duoning Biotech, BioLink, LePure Biotech, Tofflon, Applitech, Topgun Biotech, CHANSE | Cost leadership (30-50% below global), domestic market dominance, fast customization, expanding export |
| 2 | Regional specialists | BioCana (Canada), Ezi-Dock Systems (US) | Niche (connectors, docking systems), high-quality |
Technology roadmap (2027-2030):
- RFID-tracked feeding bags – RFID tags for automated inventory management, lot traceability, and real-time temperature monitoring (cold chain compliance).
- Single-use sensors integrated into bags – Embedded pH, glucose, lactate sensors (optical) for real-time feed monitoring and closed-loop control.
- 100% recyclable feeding bags – Polyethylene-only film (no EVOH) compatible with polyolefin recycling streams. Pilot stage (Duoning, LePure).
With 4.3% CAGR and 7.8 million units sold in 2024 (projected 10M+ by 2030), the biopharmaceutical feeding bag market benefits from biopharma growth (mAbs, vaccines, cell therapies), single-use adoption, and fed-batch manufacturing. Risks include plastic waste concerns (environmental regulations), supply chain disruptions (film resins, gamma irradiation capacity), and cost pressure from domestic Chinese manufacturers.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
